Dr. Poojitha Valasareddy, MD

Dr. Valasareddy practices at UCHealth Highlands Ranch Hospital in Highlands Ranch, Colorado, part of UCHealth.

Dr. Valasareddy's NPI, 1659715902, was assigned on April 17, 2013. Dr. Valasareddy graduated from St. George's University School of Medicine in 2013. Dr. Valasareddy holds Colorado license DR.0064252.

Dr. Valasareddy's primary practice is UCHealth Highlands Ranch Hospital, at 1500 Park Central Dr, Highlands Ranch, CO 80129 in Douglas County. The practice phone is (720) 516-1000.

Dr. Valasareddy's primary practice is UCHealth Highlands Ranch Hospital in Highlands Ranch, Colorado, part of UCHealth. Dr. Valasareddy is also affiliated with UCHealth University of Colorado Hospital. The medical group on file is University of Colorado Medicine (CU Medicine). Dmand AI also links Dr. Valasareddy to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Valasareddy practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Valasareddy's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Valasareddy's licenses on file in 2 states: Colorado and Texas.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Valasareddy treats.

CMS data shows 1,006 Medicare services from Dr. Valasareddy across 7 procedure codes in 2024, for 403 Medicare patients. Medicare paid $123,676 for them.

CMS counts 403 Medicare patients who saw Dr. Valasareddy in 2024. The largest group is 65 to 74, with 180 patients. 69% of them have high cholesterol, and 63% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Valasareddy's median patient age at 72, with 54% women.

In 2024, Dr. Valasareddy wrote 805 Medicare Part D claims for 156 patients. 75% of them were for generic drugs. CMS names the drug for 562 of them, across 18 drugs with 11 or more claims each, at $124,618 in total drug cost. In 2023, CMS named 477 claims across 17 drugs.

Dr. Valasareddy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Valasareddy as offering telehealth.

Dmand AI links 6 papers to Dr. Valasareddy, published from 2015 to 2022. 2020 was the busiest year, with 2. The most frequent topics are Antineoplastic Agents and Radiotherapy. Dr. Valasareddy's most frequent co-authors are Janice Nhan Mullins, DO, Amit Jain, MBA, MD and Lee S. Schwartzberg, MD.

CMS Open Payments shows 45 general payments to Dr. Valasareddy from 22 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 79% of the total. Seagen Inc. paid the most, $198.

Dr. Valasareddy graduated from St. George's University School of Medicine in 2013.

Dr. Valasareddy is in network with 13 carriers, including Aetna, Elevance and Cigna. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.